The cellular immune reactions to hapten-protein conjugates (in the generation of hapten-specific primary and secondary humoral responses) display a significant dependence upon carrier recognition (reviewed in reference 1). Experimental models, particularly the adoptive transfer of immunocompetent cells into irradiated hosts (2-5), have established that the cooperative interactions involved require a thymus-derived (T) lymphocyte (6) with specificity for the carrier protein (7-9) to induce an optimal response by hapten-primed, antibody-forming precursors (B cells). In vivo methods for generating carrier-reactive T-helper cells include preimmunization with free carrier before immunization with hapten-carrier conjugate (10, 11), adoptive transfer of carrier primed cells (6-9), and the use of thymus-derived cells obtained from spleens of irradiated mice injected with thymocytes and carrier (12-14). These cells, or products derived from them, have been analyzed in vlvo (12-15) and in vitro (16) (17) (18) The critical role of the macrophage in a variety of T-cell responses (19) (20) (21) (22) (23) (24) (25) suggests that an in vitro system in which macrophage-thymocyte synergy is used might be devised for generating carrier-reactive T cells. Cultured, adherent cells have been shown to substantially preserve thymocyte viability and function in vitro (26), and have been used to selectively enrich antigen-reactive T cells from mice primed in vivo (27). Until recently it has not been possible to generate carrmr-reactive T-helper cells in vitro. In 1973, Kontianen and Feldmann (28) reported the induction of carrier-specific helper T cells in vitro by using spleen and lymph node cells as a source of unprimed T cells. Subsequently, have obtained evidence that interaction between macrophages and T cells is essential to the generation of carrier-specific T-helper cells. A detailed examination of the cellular requirements, antigen specificity, or mode of action of T-helper cells generated in wtro has not been reported.
Hapten-Pnmed Spleen Cells Spleens from mine injected l.p with 25 ~g DNP-Ficoll 3-4 mo previously were removed aseptically. Cells were gently teased from the cut capsule, expressed through a no. 60-mesh stainless steel screen, and washed twice in HEPES MEM; clumps and debris were allowed to settle at unit grawty, and the supernate containing a single cell suspension was adjusted to the desired concentration for culture.
Sequentml Culture Technique. Unless stated otherwise, the standard procedure used is as follows. 1 5 × 107 nylon wool-purified, cortisone-resistant thymocytes and 5 × 105 glass-adherent PEC were cultured with carrmr antigen (0.1 ~g KLH or 0 5 ~g F~/G) in 1.0 ml HEPES MEM 10% FCS m Marbrook-Diener culture chambers. After 4 days, the cells were harvested, and the debms and glass beads were allowed to settle through a layer of FCS at unit grav:ty. The supernate was pelleted at 300 g for 7 mm and resuspended in fresh media. A quantity of the cell suspensmn contaimng 5-10 × l0 s viable cells was then transferred to cultures containing spleen cells from hapten-pmmed mice together with hapten-protem conjugates (1 ~g DNP-KLH or 5 ~g DNP-FTG). The recipient cultures contained 15 × l0 s cells After 4 days, triplicate cultures were harvested and assayed for DNP-specific plaque-forming cells (DNP-PFC) All experiments reported here were done at least three times.
PFC Assay D:rect PFC were assayed by the Cunnmgham Szenberg mod:ficatlon of the Jerne hemolytic-plaque techmque (37) with 2,4,6,-trm:trophenyl-conjugated sheep red blood cells (SRBC) (38) Specific DNP-PFC were calculated by subtracting the number of PFC formed in the presence of 5 x 10 -4 M e-DNP-L-lysine (Sigma Chemical Co., St. Louis, Mo.) from the number of PFC formed m the absence of free hapten Indirect (IgG) PFC were enumerated inhibiting direct PFC with a goat ant:-mouse ~-chain serum (>90% inhibition) and developing IgG PFC with a rabbit anti-mouse T-chain serum (39) Depletmn of T Lymphocytes w~th Antz-Thy-1 2 Serum Antl-Thy-l.2 serum (anti-O) with a plateau mlcrocytotomcity titer of 1:128 (1 ~1 serum/3 × l0 s cells) was prepared according to the method of Reif and Allen (40) A 1:3 final dilution of anti-Thy-l.2 serum in HEPES MEM was reacted with cell suspensmns of no more than 2 × 107 cells per ml for 30 min at room temperature. The cells were pelleted and resuspended m a 1:10 dilution of guinea pig complement containing 10 ~g/ml deoxyribonuclease (DNAse) (Worthington Biochemical Company, Freehold, N. J ) for 1 h at 37°C The complement had prewously been absorbed at 4°C with CBA or (B10D2 × BALB/c) F~ spleen cells (two spleens/ml). When spleen cell preparations were treated with anti-Thy-l.2 serum, dead cells were removed by the techmque ofVon Boehmer and Shortman (36) Control cells were treated identically to the anti-Thy-1 2-treated cells, except that normal AKR mouse serum was used Depletwn of Macrophages. Macrophages were removed from cell preparatmns by Sephadex G-10 column incubation according to the method of Ly and Mishell (41) with the following modlficatmns. HEPES MEM 20% FCS was used instead of Hanks' balanced salt solution, and a 1-h incubation was performed at 37°C
M~tomyc~n C Treatment of Cells. Thymocytes and macrophages at 5 × 108 cells per ml were treated with 50/~g/ml mitomycin C (Laboratory and Educatmnal Supplies, Los Angeles, Calif ) for 45 min at 37°C The cells were washed twice with a 5-rain 37°C incubation between washes. This dose diminished the DNA synthetic response of cells to mitogenic stimulatmn to less than 10% of control values, yet allowed preservation of cell viability m culture Ident~fwatmn of Cells Mononuclear phagocytes (macrophages) were identified by the ingestion of latex beads (1.1 ~m, Dow Chemical, Midland, Mmh ) during a 30-mm incubatmn at 37°C m the presence of 20% FCS (42) . Latex mgestmn was performed on all cell preparations before being dispensed for other cell marker procedures Surface lmmunoglobuhn-bearing cells were determined with a fluorescein-conjugated, thymocyte-absorbed rabbit anti-mouse lmmunoglobulin reagent (a gift from C. B. l~eimer, Center for Disease Control). Cells (1 × l0 s) m a 0.2-ml vol were incubated w:th a 1.100 final dilutmn of antlsera in 0.01 M phosphate-buffered saline (PBS), 0.1% Na azide, and 5% FCS for 30 minutes at 4°C. Cells were washed twice at 4°C over FCS, and positive cells were enumerated with an mcldent-illuminatmn Leltz fluorescent microscope T cells were determined by microcytotoxicity (43) or indirect immunofluorescence with anti-Thy-l.2 serum The latter procedure was performed essentially as descmbed by Schwartz et al (44) Cells were first incubated with either undiluted anti-Thy-l.2 serum or normal AKR mouse serum (NMS). The cells were washed and incubated with fluorescem-conjugated, rabbit anti-mouse immunoglobulln reagent The percent ofT lymphocytes was determined as the difference between the percentage of fluorescent cells in the anti-Thy-l.2 serum and the NMS-incubated preparation. Complement receptor-bearing lymphocytes (CRL) were enumerated with sheep erythrocytes coated with a subagglutinating dose of rabbit 19s anti-SRBC (Cordls Laboratories, Miami, Fla.) and mouse complement (a 1:5 dilution of AKR mouse serum previously absorbed at 4°C against SRBC) (45) Antibody-coated SRBC without complement served as control. Only cells surrounded by three or more SRBC (macrophages excluded) were considered CRL. Lymphocytes bearing receptors for the Fc portion of immunoglobulin were enumerated indirectly according to the method described by Dickler and Kunkel (46) in which aggregated human IgG and a fluorescein-conjugated, goat antihuman T-chain reagent were used (supplied by C. B. Relmer, Center for Diseases Control). The latter reagent did not bind mouse cells directly. At least 300 cells were examined for each determination. When a particular marker comprised a small percentage of the cells being examined, effort was made to examine 1,000 or more cells.
Mitogen Sttmulatton. All experiments were performed with several doses of mitogens: phytohemagglutinin, diluted according to manufacturer's instructions, 0.25-1.0 ~l/ml (Difco Laboratories); concanavalin A, 0.1-1.0 ~g/ml (Con A, Pharmacia, Piscataway, N. J.); and Salmonella enterttidts lipopolysaccharide, 1-10 ~g/ml (Difco Laboratorms). Results reported reflect optimums from dose-response curves. 1-ml cultures of 106 cells in serum-free, supplemented MEM containing 5 x 10 -5 M 2-ME were incubated for 3 days. 18 h before harvest, 1 ~Ci [3H]thymidine (6 7 Ci/mM, New England Nuclear, Boston, Mass.) was added. Cultures were harvested manually Cells were pelleted, and the pellets were precipitated with cold 5% trichloroaeetic acid, washed twice in methanol, and solubihzed at 50°C in 0.4 m] NCS reagent (Amersham/Searle Corp., Arhngton Heights, Ill.); radioactivity was determined by liquid scintfllatmn counting.
Results

Cell Preparations and the Optimal Conditions for the In Vitro Induction of Helper Cell Function.
Preliminary experiments were performed to determine the optimal thymocyte cell number, proportion of macrophages, antigen dose, and duration of the helper cell induction culture. It was found that 1.5 × 107 thymocytes and 5 × 105 macrophages cultured for 4 days with either 0.1/xg KLH or 0.5 gg FTG are the optimal conditions for generating helper cells. Cells from this culture enhance the anti-DNP PFC response of hapten-primed, spleen cell cultures to hapten-carrier conjugates. The enhancement of indirect (IgG) DNP-PFC responses varied in parallel with direct (IgM) DNP-PFC responses (Fig. 1) .
The presence of macrophages in the thymocyte cultures improves cell culture recovery and viability (25-45% viable cell recovery within the protocols outlined in Fig. 1 ), but does not obviate the addition of varying amounts of dead cells to the recipient cultures. This might affect recovery of spleen cells from the cultures and, therefore, the results expressed as DNP-PFC per culture. In the experiments reported here, individual spleen cell-culture recoveries were within 20% of the mean recovery for all cultures within any given experiment.
The characteristics of the cell preparations before and after 4 days of coculturing is shown in Table I . B-cell contamination is minimal as assessed by membrane markers (SIg, Fc, CRL) and by the absence of a response to the B-cell mitogen lipopolysaccharide (Table II) . No PFC are generated in this culture (n =9).
Nylon wool purification of corisone-resistant thymocytes yields 50-70% recovery, removes contaminating B cells, and results in an effluent population with improved viability (90-98% vs. 60-80% viability for the starting pool).
PEC obtained from mice injected with proteose peptone broth are 60-75% phagocytic as judged by uptake of polystyrene beads. Purification by adherence substantially increases the proportion of phagocytic cells. Macrophages are The major nonphagocytic component of the PEC population is T cells. Pretreatment of the adherent cell population with anti-Thy-l.2 serum and complement increases the percentage of macrophages in the population. It does not affect the generation of helper cell function, making it unlikely that the peritoneal exudate T cell contributes significantly to the generation of helper cell function in this system. Cellular Requirements for the In Vitro Induction of Helper Cells. Early in these studies, it became apparent that, under certain conditions, the thymocytemacrophage culture system nonspecifically enhanced anti-DNP-PFC responses. This is illustrated in Fig. 2 . The thymocyte-macrophage culture cells stimulated splenic anti-DNP-PFC responses when added to cultures without antigen or to those with hapten coupled to a noncross-reacting carrier (DNP-FTG) , i.e., a carrier other than the one used to prime the helper cell culture. This is evident particularly when greater numbers of helper cells are transferred. An identical This finding prompted us to more carefully examine the cellular and antigen requirements for optimal generation of specific helper cell activity (Table III) . Thymocytes cultured without macrophages are ineffective as helper cells in this system. Macrophages cultured alone with or without carrier and transferred in numbers comparable to that found in the thymocyte-macrophage culture are only marginally enhancing. Cells from thymocyte-macrophage cultures primed with carrier display optimal stimulation of splenic anti-DNP-PFC responses only when transferred with hapten conjugated to the same carrier. Transfer with carrier (not conjugated to hapten) or without antigen is not as effective. Conversely, thymocyte-macrophage cultures generated in the absence of carrier do not stimulate an optimal anti-hapten response. It is readily apparent, however, that in this system, the dependence on the appropriate carrier haptencarrier combination for optimal stimulation is a relative phenomenon. A signifi- Carrier Specificity of Helper Cells Generated In Vitro. With knowledge of the nonspecific enhancement by thymocyte-macrophage cultures, we were able to design experiments to determine whether these cultures develop significant carrier specificity. Thymocyte-macrophage cultures were generated in the presence of KLH, FyG, or without antigen. Cultures were then tested for helper cell function by transfer to hapten-primed, spleen cell cultures with either the homologous DNP-carrier conjugate, DNP conjugated to a noncross-reacting carrier, or without antigen. The results are shown in Table IV . Under these conditions, despite considerable nonspecific enhancement of background anti-DNP-PFC responses, optimal enhancement is seen only in a homologous-carrier, hapten-carrier combination. In this sense the culture can be considered to develop carrier-specific helper cells (designated ATCKLH or ATCF~G in the tables).
Nature of the Active Cell. Table V indicates that the cell generated in thymocyte-macrophage culture which is active in enhancing carrier-specific and nonspecific anti-DNP-PFC responses is a T cell. Treatment of the culture with anti-Thy-l.2 serum and complement before transfer abolishes both the carrierspecific and nonspecific stimulation. That the abolition of enhancement by antiThy-l.2 serum treatment was not caused by trivial effects such as the addition of dead cells to the second culture or the generation of immune complexes was confirmed by mixing cells treated with anti-Thy-l.2 serum with cells treated with NMS. When macrophages are removed from the thymocyte-macrophage culture before transfer, no significant effect is seen (Table V) . The active cell is therefore a T cell.
Requirement for In Vitro T-CeU Proliferation in the Generation of Functmnal T-Helper Cells.
In vivo models of T-helper cell generation require a critical 2-to 3-day period ofT-cell proliferation in the presence of antigen. Once generated, the T-helper cell is functionally resistant to X-irradiation or anti-mitotic drugs (9, 14, 47-49). It was therefore of interest to examine whether cellular proliferation was required in the thymocyte-macrophage culture system before helper cell activity was manifest.
Thymocyte-macrophage cultures were treated with mitomycin C, either at the initiation of culture or after 4 days, just before transfer, and then tested for helper cell activity. Efficacy of mitomycin C treatment was assessed by the reduction in PHA and Con A responses to less than 10% of control values. Control cultures with mitomycin C-treated cells and either untreated ATC or DNP-Ficoll (which stimulates B cells directly) were used to monitor the potential responsiveness of the recipient spleen cell cultures, i.e., to insure that any inhibition found was not due to mitomycin C leaching from the cells. The results are shown in Table VI . Mitomycin C treatment of thymocyte-macrophage preparations at the onset of culture abolished the generation of helper cell function. If the culture is treated after 4 days, just before transfer, helper cell activity can be demonstrated. This is true for both the carrier-specific and nonspecific enhancing effects.
In separate experiments, thymocytes and macrophages were treated separately with mitomycin C, combined with untreated macrophages or thymocytes, respectively, and cultured for 4 days with carrier protein. The abolition of helper (9, 14) .
Cooperative Interactions Between the In Vitro Generated T-Helper Cell and Hapten-Pnmed Spleen Cells.
In vitro generated helper cell function is ultimately expressed as a stimulation of B-cell maturation and proliferation to DNP-specific PFC within the spleen cell cultures. This stimulation could require additional splenic T-cell cooperation (a T-T-B-cell interaction), be mediated through cooperative effects of splenic macrophages (a T-m~b-B-cell interaction), or act directly on B cells (a T-B-cell interaction). To test this, recipient spleen cell cultures were treated with anti-Thy-l.2 serum and complement or depleted of macrophages. Effectiveness of depletion was assessed by membrane marker studies and, functionally, by the primary in vitro response to sheep erythrocytes, a response known to require T cells (50) and macrophages (51) . Preservation of B-cell precursors in these populations was assessed, functionally, by the DNP-PFC response to the T-independent antigen, DNP-Ficoll (52) .
Results of T-cell depletion experiments are shown in Table VII . Splenic T cells are not absolutely required for the carrier-specific or nonspecific enhancement of the DNP-PFC response by T-helper cells generated in vitro.
Macrophage depletion of the responding spleen cell culture, sufficient to abrogate the primary in vitro response to SRBC, markedly blunts the carrierspecific enhancement, but has little or no effect on nonspecific enhancement. It is noteworthy that macrophages had to be removed from both the spleen cell population and the transferred thymocyte-macrophage culture in order for these differences to be observed (Table VIII) . Apparently, the small number of macrophages transferred with the cultured thymocytes is sufficient to restore the carrier-specific stimulation of macrophage-depleted spleen cultures. 
TABLE VII
Effect of In Vitro Generated Helper Cells on T-Depleted Spleen
Discussion
The present work was designed to establish the conditions for a reliable in vitro system of generating T-helper cells by using well-defined populations of cells. Cortisone-resistant thymocytes were selected because they represent a more mature population of thymus cells enriched for helper cell precursors (53) . Nylon wool filtration of thymocytes and combination of these cells with adherent, peritoneal exudate macrophages effectively establish a viable thymocyte culture which can be primed with carrier protein to develop significant carrierspecific T-helper cell function (Tables III-V) .
B-cell contamination in this culture system is negligible (Tables I and II) . Minor nonphagocytic or nonthymocytic cellular components in this culture system are peritoneal exudate T cells. These cells are reportedly a good source of antigen-reactive T cells (44) . Several lines of evidence mitigate against a major role for this cell in the system described. Anti-Thy-l.2 serum and complement treatment of the adherent cell population before combination with thymocytes does not affect the generation of helper cells. Pretreatment of the adherent cell population with mitomycin C does not affect the generation of helper cells, whereas pretreatment of the thymocytes or the combined culture (Table VI) abolished helper cell generation.
With the cell populations described in this communication, our results confirm the basic observations of (Tables III and V) . We extend these results to show that thymocyte proliferation is required for the induction of functional T-helper cells (Table VI) , and that these cells display an antigen-specific as well as nonspecific capacity to stimulate B-cell responses to antigen (Tables III and IV) .
The macrophage has been shown to be essential to a variety of T-cell responses, including antigen presentation (19) (20) (21) , T-cell proliferation in the presence of antigen (22) (23) , mitogen responsiveness (24 , Table II) , and the mixed lymphocyte reaction (25) . Macrophages improve thymocyte cell culture recovery and viability (26) .
The antigen requirements (Table III) and specificity (Table IV) of this culture system suggest a more critical role for the macrophage than merely facilitating thymocyte integrity in vitro. The experiments with mitomycin C (Table VI) indicate that T-cell proliferation is required in this system before the expression of helper cell function. Based on our data, the predominant role of the macrophage in this system is in facilitating the proliferative expansion of thymocytes into functional carrier-reactive helper cells. While it is probable from available data (19, 21, 22, 30) that antigen acts in the induction of specific T-cell prolifera-tion, we have not presented formal evidence that this is the mechanism in our system. It is possible that the thymocyte proliferation in this system is undirected and that antigen-bound macrophages serve to selectively enrich proliferating cells which are antigen specific. The requirement for T-cell proliferation distinguishes this mechanism of generating helper cells from another in vitro system described by Ben-Sasson et al. (27) , where antigen-pulsed macrophages have been used to enrich antigen-specific T cells from mice presensitized in vivo. Their system enriches by selection rather than proliferation.
Analysis of the antigen requirements reveals that carrier-specific and nonspecific T-helper cell function is generated in vitro. Optimal stimulation of splenic DNP-PFC responses to a hapten-carrier conjugate is provided by thymocytemacrophage cultures primed to the carrier. Stimulation is substantially less if the helper cell culture is not primed with carrier or is primed with a noncrossreacting carrier (Tables III and IV ). In the sense that optimal enhancement is seen only in the appropriate combination of carrier in the helper cell culture and carrier-hapten conjugate in the assay culture, this system generates specific, carrier-reactive T-helper cells.
Enhancement of the anti-DNP-PFC response is also seen under conditions that cannot be considered antigen specific. Both carrier-primed and unprimed cells from helper cell cultures stimulate a small but reproducible enhancement of background splenic DNP-PFC responses in the absence of hapten-carrier conjugate (Tables III and IV) . This nonspecific effect is particularly striking if greater numbers of activated T cells are used (Fig. 2) . The nonspecific response is further enhanced in the second culture in the presence of hapten coupled to a noncross-reacting carrier (Fig. 2, Table IV ). The marginal but consistent augmentation of the nonspecific response in the presence of an irrelevant haptencarrier conjugate requires that macrophages be present in the assay culture (Table VIII) , and its mechanism is further clarified in the companion paper.
Nonantigen-specific enhancing effects of activated T cells have been described in other systems. The activation of T cells to histocompatibility differences results in a cell active in enhancing B-cell responses to T-dependent antigens (1, (53) (54) (55) . When looked for, nonspecific enhancing effects have even been demonstrated with in vivo generated, carrier-specific T-helper cells (18, 56) . In their system, Erb and Feldmann do not describe an enhancing effect of cultured T cells that is independent of antigen (29-31). There are several possible reasons for this discrepancy. They used unprimed spleen cells as recipients of activated T cells, whereas we used hapten-primed spleen cells. In our system, the major differences between primed and unprimed spleen cells in culture are in the magnitude of the IgM-PFC response and the fact that IgG-PFC are not detected unless hapten-primed cells are used. It is noteworthy in this regard that the allogeneic effect, a T-cell derived nonspecific stimulation of B-cell responses to antigen, is generally not demonstrable in unprimed cells (1, 57) . The low levels of background DNP-PFC in unprimed cells, the inherent variability between cultures, polyclonal B-cell activation from other sources in vitro such as FCS (55) , and the method of enumerating DNP-specific PFC (hapten inhibition vs. subtraction technique), make precise demonstration of a nonspecific stimulatory effect on unprimed cells more difficult.
Macrophage depletion of recipient spleen cell cultures revealed a difference in the mechanism of the specific and nonspecific stimulation of B-cell responses by cultured T-helper cells. It is difficult to totally deplete a cell population of macrophages. In our hands, the most effective method without proportionate changes in T and B cells is Sephadex G-10 column incubation. Macrophage depletion of both the spleen cell cultures and the transferred thymocyte culture markedly blunts the carrier-specific effect of in vitro generated T-helper cells (Table VIII) , findings consistent with those observed with in vivo generated Thelper cells (16) . Although macrophages are not the active cell (Tables III and  IV) , the small number transferred with the primed thymocyte-culture cells is apparently sufficient to restore the T-m~b-B-cell interaction in macrophagedepleted spleen cell cultures. The nonspecific enhancement of background DNP-PFC due to cultured thymocytes does not require additional macrophage interaction and appears to act directly on B cells. Summary A sequential mouse cell culture system is described for the induction and assay of T-helper cells. Unprimed, cortisone-resistant, nylon wool-purified thymocytes cultured with adherent peritoneal exudate cells can be primed in vitro with soluble carrier protein to generate carrier-reactive helper cells. These cultured cells enhance the anti-hapten plaque-forming response of haptenprimed spleen cell cultures to hapten carrier conjugates. The culture conditions, cellular manipulations, and antigen requirements for the optimal induction of helper cells with these purified cell populations is presented. The active helper cell generated in this culture system is a thymus-derived cell which requires macrophages for its induction and must be proliferate in vitro before the manifestation of helper-cell function. Helper cells generated in vitro stimulate both carrier-specific and nonspecific enhancement of splenic anti-hapten responses. The carrier-specific and nonspecific enhancement can be distinguished by the requirement for antigen in the helper cell and spleen cell cultures, the dose of helper cells added to the spleen cell cultures, and by the requirement for additional splenic adherent accessory cell interactions.
